Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2026-05-05 16:58:47 ET · period of report 2026-05-01 · accession 0000875320-26-000179 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-05 16:58 | 2026-05-01 | VRTX | Garber Alan M | Dir | A - Grant | $0.00 | +472 | 7,344 | +7% | $0 |
| D | 2026-05-05 16:58 | 2026-05-01 | VRTX | Garber Alan M | Dir | A - Grant | $0.00 | +1,433 | 1,433 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-01 | A | A | 472 | $0.00 | 7,344 | D | — | — | (F1) Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-05-01 | A | A | 1,433 | $0.00 | 1,433 | D | $424.45 · — to 2036-04-30 | 1,433 Common Stock | (F2) Fully vested. |